These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3051271)

  • 1. [Medical disability expertise in systemic scleroderma].
    Shabel'nik VI; Tsyban' ME; Filiuk VF; Eliseĭkina LV; Lanchuk SG
    Revmatologiia (Mosk); 1988; (2):23-6. PubMed ID: 3051271
    [No Abstract]   [Full Text] [Related]  

  • 2. [Assessment of the state of the cardiovascular system in the disability evaluation of patients with systemic lupus erythematosus and scleroderma].
    Zhabina TN; Morozova RZ; Otkalenko IuK
    Vrach Delo; 1977 Nov; (11):72-5. PubMed ID: 595566
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of work capacity of patients with systemic lupus erythematosus and systemic scleroderma].
    Timeskov IS; Chirkina SS; Dolgobvorova KF; Gil'fanov RN; Zhuravleva SI
    Ter Arkh; 1979; 51(1):68-71. PubMed ID: 432836
    [No Abstract]   [Full Text] [Related]  

  • 4. [The evolution of the concepts of systemic scleroderma].
    Guseva NG
    Ter Arkh; 1995; 67(5):50-3. PubMed ID: 7638781
    [No Abstract]   [Full Text] [Related]  

  • 5. Validity of the scleroderma functional assessment questionnaire.
    Poole JL; Brower L
    J Rheumatol; 2004 Feb; 31(2):402-3. PubMed ID: 14760822
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biological age in patients with progressive scleroderma].
    Sauer I; Ries W; Mittag M; Haustein UF
    Z Gerontol Geriatr; 1996; 29(3):223-32. PubMed ID: 8767020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Work capacity assessment of systemic lupus erythematosus patients during the initial examination at the Medical Commission for Determination of Disability].
    Tarasov AN; Chirkina SS; Afanas'eva IK; Dolgodvorova KF; Prudnikov AM
    Ter Arkh; 1984; 56(5):36-9. PubMed ID: 6463884
    [No Abstract]   [Full Text] [Related]  

  • 8. [Survival and prognostic significance of a kidney lesion in systemic scleroderma].
    Guseva NG; Anikina NV; Balabanova RM
    Ter Arkh; 1982; 54(7):99-102. PubMed ID: 7135234
    [No Abstract]   [Full Text] [Related]  

  • 9. [Scleroatrophic lichen and its relation to scleroderma].
    Kalamkarian AA; Fedorova EG
    Vestn Dermatol Venerol; 1982; (12):4-7. PubMed ID: 7158014
    [No Abstract]   [Full Text] [Related]  

  • 10. [The evolution of juvenile systemic scleroderma].
    Starovoĭtova MN; Guseva NG
    Ter Arkh; 1997; 69(11):55-60. PubMed ID: 9483750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Work disability expertise on persons with a single kidney and certain urological diseases].
    Orlov AP; Trapenznikova MF; Mal'tseva LM; Melamed SB
    Urol Nefrol (Mosk); 1973; 38(2):10-4. PubMed ID: 4756555
    [No Abstract]   [Full Text] [Related]  

  • 12. A cross-sectional comparison of three self-reported functional indices in scleroderma.
    Smyth AE; MacGregor AJ; Mukerjee D; Brough GM; Black CM; Denton CP
    Rheumatology (Oxford); 2003 Jun; 42(6):732-8. PubMed ID: 12730528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the burden of scleroderma disease in Spain.
    Villaverde-Hueso A; Sánchez-Valle E; Alvarez E; Morant C; Carreira PE; Martín-Arribas MC; Gènova R; Ramírez-González A; de la Paz MP
    J Rheumatol; 2007 Nov; 34(11):2236-42. PubMed ID: 17918783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
    LeRoy EC; Black C; Fleischmajer R; Jablonska S; Krieg T; Medsger TA; Rowell N; Wollheim F
    J Rheumatol; 1988 Feb; 15(2):202-5. PubMed ID: 3361530
    [No Abstract]   [Full Text] [Related]  

  • 15. [Visceral lesions in systemic scleroderma].
    Shub NI
    Vrach Delo; 1973 May; 5():39-42. PubMed ID: 4757731
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis.
    Kuwana M; Sato S; Kikuchi K; Kawaguchi Y; Fujisaku A; Misaki Y; Hatamochi A; Kondo H; Takehara K
    J Rheumatol; 2003 Jun; 30(6):1253-8. PubMed ID: 12784399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis.
    Malcarne VL; Hansdottir I; McKinney A; Upchurch R; Greenbergs HL; Henstorf GH; Furst DE; Clements PJ; Weisman MH
    J Rheumatol; 2007 Feb; 34(2):359-67. PubMed ID: 17304659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of a combination of systemic scleroderma with diffuse eosinophilic fasciitis].
    Krasovskiĭ II; Shkodkin IV; Vladimirova NN
    Ter Arkh; 1996; 68(9):84-5. PubMed ID: 9005625
    [No Abstract]   [Full Text] [Related]  

  • 19. Using a self-reported functional score to assess disease progression in systemic sclerosis.
    Serednicka K; Smyth AE; Black CM; Denton CP
    Rheumatology (Oxford); 2007 Jul; 46(7):1107-10. PubMed ID: 17426141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of systemic scleroderma].
    Guĭda PP
    Klin Med (Mosk); 1983 Jun; 61(6):82-5. PubMed ID: 6887774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.